悪性黒色腫治療の世界市場2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Malignant Melanoma Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0GIR-00630 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、124ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、悪性黒色腫治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。悪性黒色腫治療の種類別市場規模（外科療法、放射線療法、化学療法、生物学的療法・標的療法）、用途別市場規模（病院、クリニック、外来手術センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Bristol-Myers Squibb、Navidea Biopharmaceuticals、GSK、Enzon Pharmaceuticals、Roche、Exelixis、Ono Pharmaceutical、Pfizer、Merck、Novartis、Aptose Biosciences、Takeda Pharmaceutical、Amgen、AstraZeneca、Daiichi Sankyo、Pierre Fabre Group、Avax Technologies、Qiagen、Sanofi、Clinigen Group、Biogen ・地域別グローバル市場分析 2015年-2020年 ・悪性黒色腫治療の北米市場（アメリカ、カナダ、メキシコ） ・悪性黒色腫治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・悪性黒色腫治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・悪性黒色腫治療の南米市場（ブラジル、アルゼンチン） ・悪性黒色腫治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：外科療法、放射線療法、化学療法、生物学的療法・標的療法 ・用途別分析：病院、クリニック、外来手術センター、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The Malignant Melanoma Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global Malignant Melanoma Treatment sales will be xx in 2020 from Malignant Melanoma Treatment million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Malignant Melanoma Treatment market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the Malignant Melanoma Treatment industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Malignant Melanoma Treatment and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation
Malignant Melanoma Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Malignant Melanoma Treatment market has been segmented into:
Surgical Therapy
Radiation Therapy
Chemotherapy
Biological Therapy/Targeted Therapy

By Application, Malignant Melanoma Treatment has been segmented into:
Hospitals
Clinics
Ambulatory Surgical Centers
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Malignant Melanoma Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Malignant Melanoma Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Malignant Melanoma Treatment market.

The report offers in-depth assessment of the growth and other aspects of the Malignant Melanoma Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Malignant Melanoma Treatment Market Share Analysis
Malignant Melanoma Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Malignant Melanoma Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Malignant Melanoma Treatment sales, revenue and market share for each player covered in this report.

The major players covered in Malignant Melanoma Treatment are:
Bristol-Myers Squibb
Navidea Biopharmaceuticals
GSK
Enzon Pharmaceuticals
Roche
Exelixis
Ono Pharmaceutical
Pfizer
Merck
Novartis
Aptose Biosciences
Takeda Pharmaceutical
Amgen
AstraZeneca
Daiichi Sankyo
Pierre Fabre Group
Avax Technologies
Qiagen
Sanofi
Clinigen Group
Biogen
Among other players domestic and global, Malignant Melanoma Treatment market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

レポート目次

---

1 Malignant Melanoma Treatment Market Overview
1.1 Product Overview and Scope of Malignant Melanoma Treatment
1.2 Classification of Malignant Melanoma Treatment by Therapy
1.2.1 Global Malignant Melanoma Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Malignant Melanoma Treatment Revenue Market Share by Therapy in 2019
1.2.3 Surgical Therapy
1.2.4 Radiation Therapy
1.2.5 Chemotherapy
1.2.6 Biological Therapy/Targeted Therapy
1.3 Global Malignant Melanoma Treatment Market by End Users
1.3.1 Overview: Global Malignant Melanoma Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Global Malignant Melanoma Treatment Market by Regions
1.4.1 Global Malignant Melanoma Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Malignant Melanoma Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Malignant Melanoma Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Malignant Melanoma Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Malignant Melanoma Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Malignant Melanoma Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Malignant Melanoma Treatment Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Malignant Melanoma Treatment Industry Impact
1.5.1 COVID-19 Potential Implications for the Malignant Melanoma Treatment
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Malignant Melanoma Treatment
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Bristol-Myers Squibb
2.1.1 Bristol-Myers Squibb Details
2.1.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bristol-Myers Squibb SWOT Analysis
2.1.4 Bristol-Myers Squibb Product and Services
2.1.5 Bristol-Myers Squibb Malignant Melanoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Navidea Biopharmaceuticals
2.2.1 Navidea Biopharmaceuticals Details
2.2.2 Navidea Biopharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Navidea Biopharmaceuticals SWOT Analysis
2.2.4 Navidea Biopharmaceuticals Product and Services
2.2.5 Navidea Biopharmaceuticals Malignant Melanoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 GSK SWOT Analysis
2.3.4 GSK Product and Services
2.3.5 GSK Malignant Melanoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Enzon Pharmaceuticals
2.4.1 Enzon Pharmaceuticals Details
2.4.2 Enzon Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Enzon Pharmaceuticals SWOT Analysis
2.4.4 Enzon Pharmaceuticals Product and Services
2.4.5 Enzon Pharmaceuticals Malignant Melanoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Roche SWOT Analysis
2.5.4 Roche Product and Services
2.5.5 Roche Malignant Melanoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Exelixis
2.6.1 Exelixis Details
2.6.2 Exelixis Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Exelixis SWOT Analysis
2.6.4 Exelixis Product and Services
2.6.5 Exelixis Malignant Melanoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Ono Pharmaceutical
2.7.1 Ono Pharmaceutical Details
2.7.2 Ono Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Ono Pharmaceutical SWOT Analysis
2.7.4 Ono Pharmaceutical Product and Services
2.7.5 Ono Pharmaceutical Malignant Melanoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Pfizer SWOT Analysis
2.8.4 Pfizer Product and Services
2.8.5 Pfizer Malignant Melanoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Merck
2.9.1 Merck Details
2.9.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Merck SWOT Analysis
2.9.4 Merck Product and Services
2.9.5 Merck Malignant Melanoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Novartis SWOT Analysis
2.10.4 Novartis Product and Services
2.10.5 Novartis Malignant Melanoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.11 Aptose Biosciences
2.11.1 Aptose Biosciences Details
2.11.2 Aptose Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Aptose Biosciences SWOT Analysis
2.11.4 Aptose Biosciences Product and Services
2.11.5 Aptose Biosciences Malignant Melanoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.12 Takeda Pharmaceutical
2.12.1 Takeda Pharmaceutical Details
2.12.2 Takeda Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Takeda Pharmaceutical SWOT Analysis
2.12.4 Takeda Pharmaceutical Product and Services
2.12.5 Takeda Pharmaceutical Malignant Melanoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.13 Amgen
2.13.1 Amgen Details
2.13.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Amgen SWOT Analysis
2.13.4 Amgen Product and Services
2.13.5 Amgen Malignant Melanoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.14 AstraZeneca
2.14.1 AstraZeneca Details
2.14.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 AstraZeneca SWOT Analysis
2.14.4 AstraZeneca Product and Services
2.14.5 AstraZeneca Malignant Melanoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.15 Daiichi Sankyo
2.15.1 Daiichi Sankyo Details
2.15.2 Daiichi Sankyo Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Daiichi Sankyo SWOT Analysis
2.15.4 Daiichi Sankyo Product and Services
2.15.5 Daiichi Sankyo Malignant Melanoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.16 Pierre Fabre Group
2.16.1 Pierre Fabre Group Details
2.16.2 Pierre Fabre Group Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Pierre Fabre Group SWOT Analysis
2.16.4 Pierre Fabre Group Product and Services
2.16.5 Pierre Fabre Group Malignant Melanoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.17 Avax Technologies
2.17.1 Avax Technologies Details
2.17.2 Avax Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Avax Technologies SWOT Analysis
2.17.4 Avax Technologies Product and Services
2.17.5 Avax Technologies Malignant Melanoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.18 Qiagen
2.18.1 Qiagen Details
2.18.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Qiagen SWOT Analysis
2.18.4 Qiagen Product and Services
2.18.3 Qiagen Malignant Melanoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.19 Sanofi
2.19.1 Sanofi Details
2.19.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Sanofi SWOT Analysis
2.19.4 Sanofi Product and Services
2.19.5 Sanofi Malignant Melanoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.20 Clinigen Group
2.20.1 Clinigen Group Details
2.20.2 Clinigen Group Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Clinigen Group SWOT Analysis
2.20.4 Clinigen Group Product and Services
2.20.5 Clinigen Group Malignant Melanoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.21 Biogen
2.21.1 Biogen Details
2.21.2 Biogen Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 Biogen SWOT Analysis
2.21.4 Biogen Product and Services
2.21.5 Biogen Malignant Melanoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Malignant Melanoma Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Malignant Melanoma Treatment Players Market Share
3.2.2 Top 10 Malignant Melanoma Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Malignant Melanoma Treatment Revenue and Market Share by Regions
4.2 North America Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
5 North America Malignant Melanoma Treatment Revenue by Countries
5.1 North America Malignant Melanoma Treatment Revenue by Countries (2015-2020)
5.2 USA Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
6 Europe Malignant Melanoma Treatment Revenue by Countries
6.1 Europe Malignant Melanoma Treatment Revenue by Countries (2015-2020)
6.2 Germany Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
6.4 France Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Malignant Melanoma Treatment Revenue by Countries
7.1 Asia-Pacific Malignant Melanoma Treatment Revenue by Countries (2015-2020)
7.2 China Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
7.5 India Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
8 South America Malignant Melanoma Treatment Revenue by Countries
8.1 South America Malignant Melanoma Treatment Revenue by Countries (2015-2020)
8.2 Brazil Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Malignant Melanoma Treatment by Countries
9.1 Middle East & Africa Malignant Melanoma Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Malignant Melanoma Treatment Revenue and Market Share by Therapy (2015-2020)
10.2 Global Malignant Melanoma Treatment Market Forecast by Therapy (2019-2024)
10.3 Surgical Therapy Revenue Growth Rate (2015-2025)
10.4 Radiation Therapy Revenue Growth Rate (2015-2025)
10.5 Chemotherapy Revenue Growth Rate (2015-2025)
10.6 Biological Therapy/Targeted Therapy Revenue Growth Rate (2015-2025)
11 Global Malignant Melanoma Treatment Market Segment by End Users
11.1 Global Malignant Melanoma Treatment Revenue Market Share by End Users (2015-2020)
11.2 Malignant Melanoma Treatment Market Forecast by End Users (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Ambulatory Surgical Centers Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Malignant Melanoma Treatment Market Size Forecast (2021-2025)
12.1 Global Malignant Melanoma Treatment Market Size Forecast (2021-2025)
12.2 Global Malignant Melanoma Treatment Market Forecast by Regions (2021-2025)
12.3 North America Malignant Melanoma Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Malignant Melanoma Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Malignant Melanoma Treatment Revenue Market Forecast (2021-2025)
12.6 South America Malignant Melanoma Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Malignant Melanoma Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Malignant Melanoma Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Malignant Melanoma Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Malignant Melanoma Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Malignant Melanoma Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Malignant Melanoma Treatment Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 7. Bristol-Myers Squibb Malignant Melanoma Treatment Major Business
Table 8. Bristol-Myers Squibb Malignant Melanoma Treatment Total Revenue (USD Million) (2017-2018)
Table 9. Bristol-Myers Squibb SWOT Analysis
Table 10. Bristol-Myers Squibb Malignant Melanoma Treatment Product and Solutions
Table 11. Bristol-Myers Squibb Malignant Melanoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Navidea Biopharmaceuticals Corporate Information, Location and Competitors
Table 13. Navidea Biopharmaceuticals Malignant Melanoma Treatment Major Business
Table 14. Navidea Biopharmaceuticals Malignant Melanoma Treatment Total Revenue (USD Million) (2018-2019)
Table 15. Navidea Biopharmaceuticals SWOT Analysis
Table 16. Navidea Biopharmaceuticals Malignant Melanoma Treatment Product and Solutions
Table 17. Navidea Biopharmaceuticals Malignant Melanoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. GSK Corporate Information, Location and Competitors
Table 19. GSK Malignant Melanoma Treatment Major Business
Table 20. GSK Malignant Melanoma Treatment Total Revenue (USD Million) (2017-2018)
Table 21. GSK SWOT Analysis
Table 22. GSK Malignant Melanoma Treatment Product and Solutions
Table 23. GSK Malignant Melanoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Enzon Pharmaceuticals Corporate Information, Location and Competitors
Table 25. Enzon Pharmaceuticals Malignant Melanoma Treatment Major Business
Table 26. Enzon Pharmaceuticals Malignant Melanoma Treatment Total Revenue (USD Million) (2017-2018)
Table 27. Enzon Pharmaceuticals SWOT Analysis
Table 28. Enzon Pharmaceuticals Malignant Melanoma Treatment Product and Solutions
Table 29. Enzon Pharmaceuticals Malignant Melanoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Roche Corporate Information, Location and Competitors
Table 31. Roche Malignant Melanoma Treatment Major Business
Table 32. Roche Malignant Melanoma Treatment Total Revenue (USD Million) (2017-2018)
Table 33. Roche SWOT Analysis
Table 34. Roche Malignant Melanoma Treatment Product and Solutions
Table 35. Roche Malignant Melanoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Exelixis Corporate Information, Location and Competitors
Table 37. Exelixis Malignant Melanoma Treatment Major Business
Table 38. Exelixis Malignant Melanoma Treatment Total Revenue (USD Million) (2017-2018)
Table 39. Exelixis SWOT Analysis
Table 40. Exelixis Malignant Melanoma Treatment Product and Solutions
Table 41. Exelixis Malignant Melanoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Ono Pharmaceutical Corporate Information, Location and Competitors
Table 43. Ono Pharmaceutical Malignant Melanoma Treatment Major Business
Table 44. Ono Pharmaceutical Malignant Melanoma Treatment Total Revenue (USD Million) (2017-2018)
Table 45. Ono Pharmaceutical SWOT Analysis
Table 46. Ono Pharmaceutical Malignant Melanoma Treatment Product and Solutions
Table 47. Ono Pharmaceutical Malignant Melanoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Pfizer Corporate Information, Location and Competitors
Table 49. Pfizer Malignant Melanoma Treatment Major Business
Table 50. Pfizer Malignant Melanoma Treatment Total Revenue (USD Million) (2017-2018)
Table 51. Pfizer SWOT Analysis
Table 52. Pfizer Malignant Melanoma Treatment Product and Solutions
Table 53. Pfizer Malignant Melanoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Merck Corporate Information, Location and Competitors
Table 55. Merck Malignant Melanoma Treatment Major Business
Table 56. Merck Malignant Melanoma Treatment Total Revenue (USD Million) (2017-2018)
Table 57. Merck SWOT Analysis
Table 58. Merck Malignant Melanoma Treatment Product and Solutions
Table 59. Merck Malignant Melanoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Novartis Corporate Information, Location and Competitors
Table 61. Novartis Malignant Melanoma Treatment Major Business
Table 62. Novartis Malignant Melanoma Treatment Total Revenue (USD Million) (2017-2018)
Table 63. Novartis SWOT Analysis
Table 64. Novartis Malignant Melanoma Treatment Product and Solutions
Table 65. Novartis Malignant Melanoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Aptose Biosciences Corporate Information, Location and Competitors
Table 67. Aptose Biosciences Malignant Melanoma Treatment Major Business
Table 68. Aptose Biosciences Malignant Melanoma Treatment Total Revenue (USD Million) (2017-2018)
Table 69. Aptose Biosciences SWOT Analysis
Table 70. Aptose Biosciences Malignant Melanoma Treatment Product and Solutions
Table 71. Aptose Biosciences Malignant Melanoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Takeda Pharmaceutical Corporate Information, Location and Competitors
Table 73. Takeda Pharmaceutical Malignant Melanoma Treatment Major Business
Table 74. Takeda Pharmaceutical Malignant Melanoma Treatment Total Revenue (USD Million) (2017-2018)
Table 75. Takeda Pharmaceutical SWOT Analysis
Table 76. Takeda Pharmaceutical Malignant Melanoma Treatment Product and Solutions
Table 77. Takeda Pharmaceutical Malignant Melanoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Amgen Corporate Information, Location and Competitors
Table 79. Amgen Malignant Melanoma Treatment Major Business
Table 80. Amgen Malignant Melanoma Treatment Total Revenue (USD Million) (2017-2018)
Table 81. Amgen SWOT Analysis
Table 82. Amgen Malignant Melanoma Treatment Product and Solutions
Table 83. Amgen Malignant Melanoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. AstraZeneca Corporate Information, Location and Competitors
Table 85. AstraZeneca Malignant Melanoma Treatment Major Business
Table 86. AstraZeneca Malignant Melanoma Treatment Total Revenue (USD Million) (2017-2018)
Table 87. AstraZeneca SWOT Analysis
Table 88. AstraZeneca Malignant Melanoma Treatment Product and Solutions
Table 89. AstraZeneca Malignant Melanoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Daiichi Sankyo Corporate Information, Location and Competitors
Table 91. Daiichi Sankyo Malignant Melanoma Treatment Major Business
Table 92. Daiichi Sankyo Malignant Melanoma Treatment Total Revenue (USD Million) (2017-2018)
Table 93. Daiichi Sankyo SWOT Analysis
Table 94. Daiichi Sankyo Malignant Melanoma Treatment Product and Solutions
Table 95. Daiichi Sankyo Malignant Melanoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Pierre Fabre Group Corporate Information, Location and Competitors
Table 97. Pierre Fabre Group Malignant Melanoma Treatment Major Business
Table 98. Pierre Fabre Group Malignant Melanoma Treatment Total Revenue (USD Million) (2017-2018)
Table 99. Pierre Fabre Group SWOT Analysis
Table 100. Pierre Fabre Group Malignant Melanoma Treatment Product and Solutions
Table 101. Pierre Fabre Group Malignant Melanoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. Avax Technologies Corporate Information, Location and Competitors
Table 103. Avax Technologies Malignant Melanoma Treatment Major Business
Table 104. Avax Technologies Malignant Melanoma Treatment Total Revenue (USD Million) (2017-2018)
Table 105. Avax Technologies SWOT Analysis
Table 106. Avax Technologies Malignant Melanoma Treatment Product and Solutions
Table 107. Avax Technologies Malignant Melanoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Qiagen Malignant Melanoma Treatment Therapy and End Users
Table 109. Qiagen Malignant Melanoma Treatment Major Business
Table 110. Qiagen Malignant Melanoma Treatment Total Revenue (USD Million) (2017-2018)
Table 111. Qiagen SWOT Analysis
Table 112. Qiagen Malignant Melanoma Treatment Product and Solutions
Table 113. Qiagen Malignant Melanoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 114. Sanofi Corporate Information, Location and Competitors
Table 115. Sanofi Malignant Melanoma Treatment Major Business
Table 116. Sanofi Malignant Melanoma Treatment Total Revenue (USD Million) (2017-2018)
Table 117. Sanofi SWOT Analysis
Table 118. Sanofi Malignant Melanoma Treatment Product and Solutions
Table 119. Sanofi Malignant Melanoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 120. Clinigen Group Corporate Information, Location and Competitors
Table 121. Clinigen Group Malignant Melanoma Treatment Major Business
Table 122. Clinigen Group Malignant Melanoma Treatment Total Revenue (USD Million) (2017-2018)
Table 123. Clinigen Group SWOT Analysis
Table 124. Clinigen Group Malignant Melanoma Treatment Product and Solutions
Table 125. Clinigen Group Malignant Melanoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 126. Biogen Corporate Information, Location and Competitors
Table 127. Biogen Malignant Melanoma Treatment Major Business
Table 128. Biogen Malignant Melanoma Treatment Total Revenue (USD Million) (2017-2018)
Table 129. Biogen SWOT Analysis
Table 130. Biogen Malignant Melanoma Treatment Product and Solutions
Table 131. Biogen Malignant Melanoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 132. Global Malignant Melanoma Treatment Revenue (Million USD) by Players (2015-2020)
Table 133. Global Malignant Melanoma Treatment Revenue Share by Players (2015-2020)
Table 134. Global Malignant Melanoma Treatment Revenue (Million USD) by Regions (2015-2020)
Table 135. Global Malignant Melanoma Treatment Revenue Market Share by Regions (2015-2020)
Table 136. North America Malignant Melanoma Treatment Revenue by Countries (2015-2020)
Table 137. North America Malignant Melanoma Treatment Revenue Market Share by Countries (2015-2020)
Table 138. Europe Malignant Melanoma Treatment Revenue (Million USD) by Countries (2015-2020)
Table 139. Asia-Pacific Malignant Melanoma Treatment Revenue (Million USD) by Countries (2015-2020)
Table 140. South America Malignant Melanoma Treatment Revenue by Countries (2015-2020)
Table 141. South America Malignant Melanoma Treatment Revenue Market Share by Countries (2015-2020)
Table 142. Middle East and Africa Malignant Melanoma Treatment Revenue (Million USD) by Countries (2015-2020)
Table 143. Middle East and Africa Malignant Melanoma Treatment Revenue Market Share by Countries (2015-2020)
Table 144. Global Malignant Melanoma Treatment Revenue (Million USD) by Type (2015-2020)
Table 145. Global Malignant Melanoma Treatment Revenue Share by Type (2015-2020)
Table 146. Global Malignant Melanoma Treatment Revenue Forecast by Type (2021-2025)
Table 147. Global Malignant Melanoma Treatment Revenue by Application (2015-2020)
Table 148. Global Malignant Melanoma Treatment Revenue Share by Application (2015-2020)
Table 149. Global Malignant Melanoma Treatment Revenue Forecast by Application (2021-2025)
Table 150. Global Malignant Melanoma Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Malignant Melanoma Treatment Picture
Figure 2. Global Malignant Melanoma Treatment Revenue Market Share by Therapy in 2019
Figure 3. Surgical Therapy Picture
Figure 4. Radiation Therapy Picture
Figure 5. Chemotherapy Picture
Figure 6. Biological Therapy/Targeted Therapy Picture
Figure 7. Malignant Melanoma Treatment Revenue Market Share by End Users in 2019
Figure 8. Hospitals Picture
Figure 9. Clinics Picture
Figure 10. Ambulatory Surgical Centers Picture
Figure 11. Others Picture
Figure 12. Global Malignant Melanoma Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Malignant Melanoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Malignant Melanoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Malignant Melanoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Malignant Melanoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Malignant Melanoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Malignant Melanoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Malignant Melanoma Treatment Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Malignant Melanoma Treatment Revenue Market Share in 2019
Figure 21. Global Top 10 Players Malignant Melanoma Treatment Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Malignant Melanoma Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Malignant Melanoma Treatment Revenue Market Share by Regions (2015-2020)
Figure 25. Global Malignant Melanoma Treatment Revenue Market Share by Regions in 2018
Figure 26. North America Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Europe Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 29. South America Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 31. North America Malignant Melanoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 32. North America Malignant Melanoma Treatment Revenue Market Share by Countries in 2019
Figure 33. USA Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Canada Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 36. Europe Malignant Melanoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Malignant Melanoma Treatment Revenue Market Share by Countries in 2019
Figure 38. Germany Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 39. UK Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 40. France Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Russia Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Italy Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Malignant Melanoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Malignant Melanoma Treatment Revenue Market Share by Countries in 2019
Figure 45. China Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Japan Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 47. Korea Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 48. India Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 50. South America Malignant Melanoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 51. South America Malignant Melanoma Treatment Revenue Market Share by Countries in 2019
Figure 52. Brazil Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Malignant Melanoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Malignant Melanoma Treatment Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 57. UAE Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Malignant Melanoma Treatment Revenue and Growth Rate (2015-2020)
Figure 60. Global Malignant Melanoma Treatment Revenue Share by Type (2015-2020)
Figure 61. Global Malignant Melanoma Treatment Revenue Share by Type in 2019
Figure 62. Global Malignant Melanoma Treatment Market Share Forecast by Type (2021-2025)
Figure 63. Global Surgical Therapy Revenue Growth Rate (2015-2020)
Figure 64. Global Radiation Therapy Revenue Growth Rate (2015-2020)
Figure 65. Global Chemotherapy Revenue Growth Rate (2015-2020)
Figure 66. Global Biological Therapy/Targeted Therapy Revenue Growth Rate (2015-2020)
Figure 67. Global Malignant Melanoma Treatment Revenue Share by Application (2015-2020)
Figure 68. Global Malignant Melanoma Treatment Revenue Share by Application in 2019
Figure 69. Global Malignant Melanoma Treatment Market Share Forecast by Application (2021-2025)
Figure 70. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 71. Global Clinics Revenue Growth Rate (2015-2020)
Figure 72. Global Ambulatory Surgical Centers Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Malignant Melanoma Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Malignant Melanoma Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Malignant Melanoma Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Malignant Melanoma Treatment Revenue Market Forecast (2021-2025)
Figure 78. Europe Malignant Melanoma Treatment Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Malignant Melanoma Treatment Revenue Market Forecast (2021-2025)
Figure 80. South America Malignant Melanoma Treatment Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Malignant Melanoma Treatment Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel

---